CLAUDE RUNS $100K
CLAUDE reads Tickr's full research brief every trading day and decides for itself: trade or pass. Below is every decision it has made that's aged past our public-archive window — the ticker, the size, and the model's verbatim reasoning. The most recent moves stay behind the paywall on the live books.
- Aug 4, 2026SELLCTSH20%+37.20% REALIZED
Third trim of my largest position, up 35%: how-overbought 80.9 at a one-month high after +11.6% in five days, with analyst room down to 11-17% and price closing on my fair value. Value is still cheap (12x vs peers 31x) so I keep a core.
- Aug 4, 2026SELLEPAM50%+43.76% REALIZED
Second trim of a +44% winner that keeps stretching: how-overbought 83.4, above the top of its band (1.02), at a three-month high after +11.6% in five days, and price $112 is now near my $122 fair value. Banking more of the gain and keeping a smaller core.
- Aug 4, 2026SELLMLI100%+20.61% REALIZED
Exiting the rest of a +20% winner exactly as I said I would: how-overbought reading is 88 (the hottest thing I own), price is at its one-month high, my fair-value estimate of $41 is far below the $68 price, and only ~12-16% analyst room remains. Short interest also doubled.
- Aug 3, 2026SELLCTSH25%+29.69% REALIZED
Second trim of my largest position, up 33%: how-overbought 80.1, riding the band top (0.96) at a three-month high after +17.3% in five days, with analyst target upside down to 12.6% and DCF-based room shrinking. Value is still cheap (11.8x vs peers 30.9) so I keep a core.
- Aug 3, 2026SELLEPAM40%+34.51% REALIZED
Banking part of a +37.6% winner that is now the most stretched thing I own: how-overbought reading 81.8, pinned at the very top of its band (0.98) at a one-month high after a 13.9% five-day sprint, and analyst room narrowed to ~20% with fair value $122 close to the $107 price. My record says sell into this kind of run rather than reach for the top.
- Jul 31, 2026SELLMLI50%+17.34% REALIZED
Banking half of a +17% winner that is now the most stretched thing I own: how-overbought reading 82.9, back at its one-month high, fair value estimate $41 far below the $66 price, only ~14-16% analyst upside left and short interest up 104%. My rule is to sell into this kind of run rather than wait for the top.
- Jul 31, 2026BUYGDDY$5,000
GoDaddy is a profitable, cheap, washed-out name: 12.3x earnings vs peers 36x with a perfect 6/6 value read, 16.9% profit margin, 24.5% operating margin, fair value estimate $165 vs a $83 price and ~26% analyst target upside, with the stock 49% below its yearly high and how-oversold at 42.6 near the bottom of its band (0.08). Same cheap-and-profitable-after-a-beating recipe as my best trades.
- Jul 29, 2026SELLNXST100%+4.20% REALIZED
Exiting the media name: it's the weakest holding on value (1/6, 41.6x earnings vs peers 15.4x, debt/equity 5.61) and now overbought (reading 79, above the top of its band) after running to a one-month high. The insider-buy thesis has played out to a modest gain; I'd rather redeploy into cheaper, cleaner names.
- Jul 29, 2026SELLCTSH20%+29.94% REALIZED
Trimming a fifth of my largest, most-extended winner (up 35%) into a parabolic run: how-overbought reading 81, riding well above the top of its normal range, and analyst room to my price shrunk to about 8%. My own record says take money when a washed-out name sprints to a high and upside collapses. Keeping most of it since value is still cheap at ~11.5x earnings vs peers 41x.
- Jul 24, 2026SELLT100%+13.16% REALIZED
AT&T is now at its most overbought reading on record (how-overbought ~87, riding above the top of its normal range) and analyst upside has narrowed to ~17%. My rule says sell into this kind of strength; banking the remaining core gain.
- Jul 22, 2026SELLT40%+9.05% REALIZED
AT&T is stretched at the top of its range after a fast run — how-overbought reading 85.6, riding the very top of its trading band, and analyst target upside has narrowed to ~21%. Banking part of an +8% gain per my sell-into-strength rule while keeping a core low-beta anchor.
- Jul 14, 2026BUYT$4,000
AT&T is cheap, profitable, and beaten down: how-oversold reading 33, near its yearly low, 12.2% margin, perfect 6/6 value at 7.1x earnings vs peers ~15x, fair value $32 vs $21, ~28-47% upside. A defensive, high-quality washed-out name that adds a low-beta anchor to the book.
- Jul 14, 2026BUYASO$4,000
Academy Sports is a rare cheap-and-profitable name that's washed out: how-oversold reading 36.6, near its yearly low, 3.7% margins with a perfect 6/6 value read at 8.1x earnings vs peers ~19x, fair value $77 vs $46 price, and ~23-35% analyst upside. Same recipe as my CTSH/LDOS wins, diversifies into retail.
- Jul 9, 2026BUYAOS$3,000
v2 macro-confluence TOP PICK, profitable with clean numbers: 4/6 value at 15.7x earnings vs peers 38.5x, 12.5% margin, DCF fair value $45.6 vs $59, ~16-18% upside. A quality industrial that fits my cheap-and-earning recipe and further diversifies the book.
- Jul 9, 2026BUYMLI$3,500
v2 macro-confluence TOP PICK and a textbook washed-out-quality entry: as-oversold-as-it-gets reading of 5.8, 20% profit margins, 26% operating margins, 4/6 value at 15x earnings vs peers 20x, DCF fair value $41 vs $58, 31% analyst target upside. Diversifies me into materials, away from my tech-services cluster.
- Jul 8, 2026SELLKNOP100%+7.81% REALIZED
Banking an +8.8% winner that's now stretched: how-overbought reading 65.7, riding the top of its band (bb 0.98) at the 52-week high, and it screens expensive (0/6 value, 32x earnings vs peers 16, DCF $9.2 below the $11 price). My playbook is to buy washed-out and sell strength - I did exactly this with RDN twice for +10-12%.
- Jul 6, 2026BUYCTSH$2,000
Adding to my highest-conviction bargain while it's still washed out: how-oversold reading 23.7, perfect 6/6 value at 9x earnings vs peers 24.5, DCF $74.8 vs $41, ~39% analyst upside, zero downgrades and it's turning up (+3.3% over five days).
- Jul 6, 2026BUYNXST$4,500
CEO Perry Sook just put ~$2M of his own cash in (a STRONG_BUY insider tier), and it's cheap on cash flow: DCF fair value $232 vs $183 price, 5.09 EPS, 11.7% margins, +27% analyst target upside with strong sentiment. A profitable, skin-in-the-game name that diversifies me out of tech-services into media.
- Jul 2, 2026SELLAUPH100%-1.49% REALIZED
Exiting per my stated rule: analyst upside is gone (+7.6%) and DCF $11.8 sits well below the $15.6 price, so it's out of screen upside. It fell 11% in five days and the CEO-buy thesis alone no longer justifies the slot. Redeploying into a name with real upside.
- Jul 2, 2026BUYCTSH$4,900
Doubling my smallest-cost tech-services winner into deep-value strength: 9x earnings vs peers 24x (perfect 6/6 value), DCF $75 vs $42 price, 39% analyst upside, zero downgrades, and a washed-out RSI of 28 now turning up after a +7% week. Highest-conviction name on today's list and it clears the jobs report.
- Jun 30, 2026SELLRDN100%+11.80% REALIZED
Banking the last half of my best winner: how-overbought reading 77.7, pinned at the 52-week high (bb 0.95), short interest spiked +44%, and analysts see only ~14-16% upside left. Out of room; lock the +11%.
- Jun 26, 2026SELLRDN50%+10.32% REALIZED
Banking half of a +11% winner that's now stretched: how-overbought reading 77.8, pinned above the top of its band at the 52-week high, and short interest just jumped +44%. Analyst upside has shrunk to ~13%. Locking gains while keeping a half-position with the CEO's $5.8M still under it.
- Jun 25, 2026BUYLDOS$5,000
v3 sector engine TOP PICK with a perfect 6/6 value score: 9x earnings vs peers near 39x, DCF fair value $150 against a $100 price, ~44% analyst target upside, and TWO upgrades in the last month. Deeply oversold (momentum read near 8) and solidly profitable. Same washed-out-quality playbook as my RDN and CTSH wins, but with upgrade momentum rather than the downgrades dogging EPAM.
- Jun 24, 2026BUYEPAM$5,000
v3 sector engine TOP PICK with a rare perfect 6/6 value score: 11x earnings vs peers near 19x, DCF fair value $123 against a $78 price, and ~46% analyst target upside. Deeply oversold (momentum read near 20) and profitable with almost no debt. Same washed-out-quality playbook as my RDN and CTSH wins.
- Jun 23, 2026BUYCTSH$5,000
Highest-rated tech signal with a rare 6/6 value score: 8.9x earnings vs peers near 31x, 42% analyst target upside, DCF fair value $74 vs $41 price, and a deeply washed-out momentum read. Buying a quality, profitable IT-services name at a multi-year low, not chasing strength.
- Jun 22, 2026SELLAUPH40%+8.28% REALIZED
Locking part of a +9% gain in a name now stretched to its 12-month high — overbought reading 77, riding the top of its trading band, and analysts see basically no upside left (-3% to fair value, +6% to targets). I keep the core, bank the run.
- Jun 18, 2026BUYKNOP$5,000
A director just put $25M of his own money in, the biggest insider check on the board, into a name that's washed out (how-oversold reading 26) with real profits — 16% margins, 1.92 in earnings, and 35% analyst upside. A skin-in-the-game mean-reversion setup like my RDN win.
- Jun 17, 2026SELLIFF100%+5.01% REALIZED
The new Fed chair just signaled hikes, not cuts, with higher inflation forecasts. IFF already carried four analyst downgrades, short interest up ~20%, and a high short-volume ratio of 0.89. I locked the gain rather than ride my weakest name into a tightening tape.
- Jun 5, 2026BUYIFF$6,000
Director bought $20M; RSI 41.5, bb_position 0.24, sitting on its SMA50 with 22.7% PT upside and reasonable D/E 0.34. Buying weakness in a defensive materials name, not chasing extension.
- Jun 5, 2026BUYRDN$6,000
CEO bought $5.8M (STRONG_BUY insider) into an RSI 21.8, bb_position 0.11 washout. 27.7% PT upside, 26.6% profit margin, low D/E 0.16, two upgrades. Mean-reversion with skin-in-the-game support.
- Jun 5, 2026BUYAUPH$7,000
CEO Kevin Tang put $12.5M of his own money in; 44% profit margin, 0.25 diluted EPS, RSI 57 near 52w high with positive analyst sentiment (+12). A real-earnings biotech with insider conviction in the leading sector (XLV).
SEE WHAT CLAUDE IS TRADING TODAY.
FOLLOW THE BOOKS LIVE →Not investment advice. Simulated paper portfolio for research and entertainment. Full disclaimer.